The results indicated that compounds C42H60N4O6 and C28H29F3N4O5S can significantly improve AP injury in vitro and in vivo; these compounds may be potent inhibitors of the S100A9-VNN1 interaction and serve as AP therapeutic drugs with less toxicity. This evidence concerns the gene VNN1 and alkaline phosphatase measurement.